Literature DB >> 30624638

Shedding Perspective on Extracellular Vesicle Biology in Diabetes and Associated Metabolic Syndromes.

Naureen Javeed1.   

Abstract

The etiology of diabetes and associated metabolic derailments is a complex process that relies on crosstalk between metabolically active tissues. Dysregulation of secreted factors and metabolites from islets, adipose tissue, liver, and skeletal muscle contributes to the overall progression of diabetes and metabolic syndrome. Extracellular vesicles (EVs) are circulating nanovesicles secreted by most cell types and are comprised of bioactive cargoes that are horizontally transferred to targeted cells/tissues. Accumulating evidence from the past decade implicates the role of EVs as mediators of islet cell dysfunction, inflammation, insulin resistance, and other metabolic consequences associated with diabetes. This review covers a broad spectrum of basic EV biology (i.e., biogenesis, secretion, and uptake), including a comprehensive investigation of the emerging role of EVs in β-cell autocrine/paracrine interactions and the multidirectional crosstalk in metabolically active tissues. Understanding the utility of this novel means of intercellular communication could impart insight into the development of new treatment regimens and biomarker detection to treat diabetes.

Entities:  

Mesh:

Year:  2019        PMID: 30624638      PMCID: PMC6349001          DOI: 10.1210/en.2018-01010

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  96 in total

1.  Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress.

Authors:  Akiko Eguchi; Milos Lazic; Aaron M Armando; Susan A Phillips; Roia Katebian; Spyridoula Maraka; Oswald Quehenberger; Dorothy D Sears; Ariel E Feldstein
Journal:  J Mol Med (Berl)       Date:  2016-07-09       Impact factor: 4.599

Review 2.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 3.  Exosomes: Therapy delivery tools and biomarkers of diseases.

Authors:  Lucio Barile; Giuseppe Vassalli
Journal:  Pharmacol Ther       Date:  2017-02-12       Impact factor: 12.310

4.  Circulating miRNA profiles in patients with metabolic syndrome.

Authors:  Dwi Setyowati Karolina; Subramaniam Tavintharan; Arunmozhiarasi Armugam; Sugunavathi Sepramaniam; Sharon Li Ting Pek; Michael T K Wong; Su Chi Lim; Chee Fang Sum; Kandiah Jeyaseelan
Journal:  J Clin Endocrinol Metab       Date:  2012-10-02       Impact factor: 5.958

5.  Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells.

Authors:  Davide Povero; Akiko Eguchi; Ingrid R Niesman; Nektaria Andronikou; Xavier de Mollerat du Jeu; Anny Mulya; Michael Berk; Milos Lazic; Samjana Thapaliya; Maurizio Parola; Hemal H Patel; Ariel E Feldstein
Journal:  Sci Signal       Date:  2013-10-08       Impact factor: 8.192

6.  Relationship between beta-cell mass and diabetes onset.

Authors:  A V Matveyenko; P C Butler
Journal:  Diabetes Obes Metab       Date:  2008-11       Impact factor: 6.577

7.  Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.

Authors:  Petra Hirsova; Samar H Ibrahim; Anuradha Krishnan; Vikas K Verma; Steven F Bronk; Nathan W Werneburg; Michael R Charlton; Vijay H Shah; Harmeet Malhi; Gregory J Gores
Journal:  Gastroenterology       Date:  2016-01-05       Impact factor: 22.682

8.  Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells.

Authors:  Young-Sun Lee; So Yeon Kim; Eunjung Ko; Jun-Hee Lee; Hyon-Seung Yi; Yang Jae Yoo; Jihye Je; Sang Jun Suh; Young Kul Jung; Ji Hoon Kim; Yeon Seok Seo; Hyung Joon Yim; Won-Il Jeong; Jong Eun Yeon; Soon Ho Um; Kwan Soo Byun
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

9.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

10.  Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation.

Authors:  Kirsten Ridder; Sascha Keller; Maria Dams; Anne-Kathleen Rupp; Jessica Schlaudraff; Domenico Del Turco; Julia Starmann; Jadranka Macas; Darja Karpova; Kavi Devraj; Candan Depboylu; Britta Landfried; Bernd Arnold; Karl H Plate; Günter Höglinger; Holger Sültmann; Peter Altevogt; Stefan Momma
Journal:  PLoS Biol       Date:  2014-06-03       Impact factor: 8.029

View more
  5 in total

Review 1.  Extracellular vesicles as signaling mediators in type 2 diabetes mellitus.

Authors:  Nicole Noren Hooten; Michele K Evans
Journal:  Am J Physiol Cell Physiol       Date:  2020-04-29       Impact factor: 4.249

Review 2.  Extracellular Vesicles-The Next Frontier in Endocrinology.

Authors:  Anasuya Das Gupta; Natalia Krawczynska; Erik R Nelson
Journal:  Endocrinology       Date:  2021-09-01       Impact factor: 5.051

Review 3.  Extracellular vesicles in metabolic disease.

Authors:  Naveed Akbar; Valerio Azzimato; Robin P Choudhury; Myriam Aouadi
Journal:  Diabetologia       Date:  2019-11-05       Impact factor: 10.122

4.  Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes.

Authors:  Naureen Javeed; Tracy K Her; Matthew R Brown; Patrick Vanderboom; Kuntol Rakshit; Aoife M Egan; Adrian Vella; Ian Lanza; Aleksey V Matveyenko
Journal:  Cell Rep       Date:  2021-08-24       Impact factor: 9.423

Review 5.  Research progress of extracellular vesicles in type 2 diabetes and its complications.

Authors:  Mengting Zhang; Lanfeng Wang; Zhiping Chen
Journal:  Diabet Med       Date:  2022-05-20       Impact factor: 4.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.